{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:00:37Z","timestamp":1788397237226,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.breast.2017.06.031","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T01:30:21Z","timestamp":1498872621000},"page":"S64-S69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S1","title":["The intraoperative assessment of sentinel nodes \u2013 Standards and controversies"],"prefix":"10.1016","volume":"34","author":[{"given":"M.E.M.","family":"van der Noordaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.F.D.","family":"Vrancken Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.T.","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.breast.2017.06.031_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.breast.2017.06.031_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N. Engl J Med"},{"issue":"10","key":"10.1016\/j.breast.2017.06.031_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.breast.2017.06.031_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.breast.2017.06.031_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.breast.2017.06.031_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2017.06.031_bib9","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla - surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","author":"Savolt","year":"2017","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.031_bib10","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: american society of clinical oncology clinical practice guideline update","author":"Lyman","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2017.06.031_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.breast.2017.06.031_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2008.21.7554","article-title":"Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer","volume":"28","author":"Straver","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2017.06.031_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl J Med"},{"issue":"21","key":"10.1016\/j.breast.2017.06.031_bib14","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","article-title":"Prospective validation of a 21-gene expression assay in breast cancer","volume":"373","author":"Sparano","year":"2015","journal-title":"N. Engl J Med"},{"issue":"1","key":"10.1016\/j.breast.2017.06.031_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-011-1401-x","article-title":"Radiotherapy and breast reconstruction: a meta-analysis","volume":"127","author":"Barry","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0791-5","article-title":"Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications","volume":"121","author":"Cowen","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2017.06.031_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1245\/s10434-016-5558-8","article-title":"Postmastectomy radiotherapy: an american society of clinical oncology, american society for radiation oncology, and society of surgical oncology focused guideline update","volume":"24","author":"Recht","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"9935","key":"10.1016\/j.breast.2017.06.031_bib18","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","article-title":"Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy","volume":"24","author":"FitzSullivan","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2017.06.031_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjsurg.2015.05.004","article-title":"Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients","volume":"210","author":"Snow","year":"2015","journal-title":"Am J Surg"},{"issue":"12","key":"10.1016\/j.breast.2017.06.031_bib21","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1245\/s10434-012-2386-3","article-title":"Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment","volume":"19","author":"Milgrom","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archsurg.1996.01430150079015","article-title":"The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening","volume":"131","author":"Cady","year":"1996","journal-title":"Arch. Surg Chic Ill 1960)"},{"issue":"2","key":"10.1016\/j.breast.2017.06.031_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/SLA.0b013e3182805c4a","article-title":"Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy","volume":"257","author":"Mittendorf","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.031_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-015-1613-2","article-title":"The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)","volume":"15","author":"van Roozendaal","year":"2015","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.breast.2017.06.031_bib25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","article-title":"POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases","volume":"27","author":"Goyal","year":"2015","journal-title":"Clin Oncol R Coll Radiol (Great Britain))"},{"issue":"22","key":"10.1016\/j.breast.2017.06.031_bib26","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","article-title":"Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902","volume":"19","author":"van der Hage","year":"2001","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.breast.2017.06.031_bib27","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"22","key":"10.1016\/j.breast.2017.06.031_bib28","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/SLA.0000000000001417","article-title":"Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)","volume":"262","author":"Golshan","year":"2015","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.breast.2017.06.031_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.breast.2017.06.031_bib31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.breast.2017.06.031_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","article-title":"Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis","volume":"16","author":"Kelly","year":"2009","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.breast.2017.06.031_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.21911","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer\u2013a systematic review and meta-analysis","volume":"104","author":"Tan","year":"2011","journal-title":"J Surg Oncol"},{"issue":"32","key":"10.1016\/j.breast.2017.06.031_bib34","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2017.06.031_bib35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.breast.2017.06.031_bib36","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.breast.2017.06.031_bib37","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"10.1016\/j.breast.2017.06.031_bib38","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10","key":"10.1016\/j.breast.2017.06.031_bib40","first-page":"1278","article-title":"The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"41","author":"van Nijnatten","year":"2015","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"30","key":"10.1016\/j.breast.2017.06.031_bib41","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the american college of surgeons oncology group Z1071 trial (alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2017.06.031_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.7073","article-title":"Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer","volume":"97","author":"Straver","year":"2010","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.breast.2017.06.031_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.breast.2017.06.031_bib44","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2017.06.031_bib45","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.031_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12916-015-0385-5","article-title":"Targeting and limiting surgery for patients with node-positive breast cancer","volume":"13","author":"Caudle","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.breast.2017.06.031_bib47","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","author":"Pilewskie","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2017.06.031_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10555","article-title":"Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy","author":"Koolen","year":"2017","journal-title":"Br J Surg"},{"issue":"9503","key":"10.1016\/j.breast.2017.06.031_bib49","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet (Lond Engl"},{"issue":"1","key":"10.1016\/j.breast.2017.06.031_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/bjs.7229","article-title":"Intraoperative assessment of sentinel lymph nodes in breast cancer","volume":"98","author":"Layfield","year":"2011","journal-title":"Br J Surg"},{"issue":"30","key":"10.1016\/j.breast.2017.06.031_bib51","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.breast.2017.06.031_bib52","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/bjs.5139","article-title":"Meta-analysis of sentinel node imprint cytology in breast cancer","volume":"92","author":"Tew","year":"2005","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.breast.2017.06.031_bib53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cncr.25606","article-title":"Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience","volume":"117","author":"Liu","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.breast.2017.06.031_bib54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejca.2005.12.003","article-title":"Intraoperative sentinel lymph node examination by frozen section, immunohistochemistry and imprint cytology during breast surgery\u2013a prospective study","volume":"42","author":"Celebioglu","year":"2006","journal-title":"Eur J Cancer (Oxf Engl 1990)"},{"issue":"1","key":"10.1016\/j.breast.2017.06.031_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cncr.20738","article-title":"Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma","volume":"105","author":"Cox","year":"2005","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.breast.2017.06.031_bib56","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1158\/1078-0432.CCR-06-2512","article-title":"One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients","volume":"13","author":"Tsujimoto","year":"2007","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"4","key":"10.1016\/j.breast.2017.06.031_bib57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/bjs.9386","article-title":"Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer","volume":"101","author":"Tiernan","year":"2014","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.breast.2017.06.031_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jclinpath-2011-200301","article-title":"Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification","volume":"65","author":"Cserni","year":"2012","journal-title":"J Clin Pathol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:39:03Z","timestamp":1760776743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977617305039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":58,"alternative-id":["S0960977617305039"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.031","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The intraoperative assessment of sentinel nodes \u2013 Standards and controversies","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}